We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$2.85B
AUM Growth
+$169M
Cap. Flow
+$16.4M
Cap. Flow %
0.58%
Top 10 Hldgs %
65.16%
Holding
451
New
10
Increased
153
Reduced
16
Closed
14

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$5.11M
2
LMND icon
Lemonade
LMND
+$4.4M
3
TTD icon
Trade Desk
TTD
+$3.52M
4
BSX icon
Boston Scientific
BSX
+$2.93M
5
TRP icon
TC Energy
TRP
+$2.69M

Sector Composition

Rank Sector Weight
1 Healthcare 46.71%
2 Consumer Discretionary 8.55%
3 Technology 8.03%
4 Communication Services 7.66%
5 Financials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMRN icon
376
BioMarin Pharmaceuticals
BMRN
$11.7B
$30K ﹤0.01%
400
LIN icon
377
Linde
LIN
$235B
$30K ﹤0.01%
106
EDIT icon
378
Editas Medicine
EDIT
$413M
$29K ﹤0.01%
680
SRI icon
379
Stoneridge
SRI
$200M
$29K ﹤0.01%
910
CHRW icon
380
C.H. Robinson
CHRW
$17.3B
$28K ﹤0.01%
292
KNL
381
DELISTED
Knoll, Inc.
KNL
$27K ﹤0.01%
1,630
MPAA icon
382
Motorcar Parts of America
MPAA
$261M
$26K ﹤0.01%
1,169
NTNX icon
383
Nutanix
NTNX
$16B
$26K ﹤0.01%
990
XLE icon
384
State Street Energy Select Sector SPDR ETF
XLE
$39.2B
$26K ﹤0.01%
1,052
+10
+1% +$231
GAP
385
The Gap Inc
GAP
$7.34B
$24K ﹤0.01%
821
KHC icon
386
Kraft Heinz
KHC
$31.3B
$23K ﹤0.01%
578
+6
+1% +$216
UNIT
387
Uniti Group
UNIT
$2.26B
$23K ﹤0.01%
2,112
VNT icon
388
Vontier
VNT
$4.49B
$23K ﹤0.01%
760
NPTN
389
DELISTED
NEOPHOTONICS CORP
NPTN
$23K ﹤0.01%
1,958
XLRE icon
390
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.6B
$22K ﹤0.01%
551
+6
+1% +$226
SIEN
391
DELISTED
Sientra, Inc.
SIEN
$22K ﹤0.01%
308
CDTX
392
DELISTED
Cidara Therapeutics
CDTX
$21K ﹤0.01%
387
ENLC
393
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$21K ﹤0.01%
4,836
MYO icon
394
Myomo
MYO
$38.6M
$20K ﹤0.01%
1,570
NTUS
395
DELISTED
Natus Medical Inc
NTUS
$20K ﹤0.01%
790
ENTA icon
396
Enanta Pharmaceuticals
ENTA
$378M
$19K ﹤0.01%
383
XRX icon
397
Xerox
XRX
$456M
$18K ﹤0.01%
748
+2
+0.3% +$48
EFA icon
398
iShares MSCI EAFE ETF
EFA
$78.5B
$16K ﹤0.01%
210
MCK icon
399
McKesson
MCK
$101B
$16K ﹤0.01%
85
+1
+1% +$183
SGMO
400
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$16K ﹤0.01%
1,273

Similar funds

Bollard Group's Q1 2021 Portfolio in Review

As of Q1 2021, Bollard Group held 451 positions worth $2.85B, up 6.3% from $2.69B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Bollard Group's Q1 2021 filing shows 10 new, 153 increased, 16 reduced and 14 closed positions. Its largest new stake was Lemonade: 34,100 shares worth $3.18M. The largest sale was DraftKings, an estimated $25M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bollard Group's largest Q1 2021 buy was Lemonade: 34,100 shares worth $3.18M.
  • Bollard Group added most to Gartner in Q1 2021, an estimated $5.11M increase.
  • Bollard Group's biggest Q1 2021 reduction was Eli Lilly, cutting an estimated $4.8M.
  • Bollard Group fully exited DraftKings in Q1 2021, selling an estimated $25M.
  • Bollard Group's ten largest holdings make up 65% of its $2.85B portfolio in Q1 2021.
  • Bollard Group opened 10 new positions and closed 14 in Q1 2021.
  • Bollard Group's portfolio value rose 6.3% quarter-over-quarter to $2.85B.

Based on Bollard Group's 13F filing for Q1 2021, filed 11 May 2021.